1-14 of 14
Christoph Mamot
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract P4-01-25: Safety analysis after 11 years of follow-up of the randomized phase III trial SAKK22/99: upfront chemotherapy in advanced HER2 positive breast cancer

Free
Manuela Rabaglio, Daniel Dietrich, Bernhard Scheibe, Thomas Ruhstaller, Franco Nole, Serenella Eppenberger, Christian Oehlschlegel, Dagmar Hess, Christoph Mamot, Elisabetta Munzone, Bernhard Pestalozzi, Stefan Aebi, Marcus Vetter, Beat Thuerlimann, Roger von Moos, Khalil Zaman, Olivia Pagani
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): P4-01-25.
https://doi.org/10.1158/1538-7445.SABCS22-P4-01-25
Published: 01 March 2023
View article titled, Abstract P4-01-25: Safety analysis after 11 years of follow-up of the randomized phase III trial SAKK22/99: upfront chemotherapy in advanced HER2 positive breast cancer
Journal Articles

Abstract P4-15-11: Advanced HER2 positive breast cancer treated with trastuzumab: Is combination with chemotherapy always needed? Randomized phase III trial SAKK 22/99

Free
Olivia Pagani, Dirk Klingbiel, Thomas Ruhstaller, Franco Nolè, Serenella Eppenberger, Christian Oehlschlegel, Jürg Bernhard, Peter Brauchli, Dagmar Hess, Christoph Mamot, Elisabetta Munzone, Bernhard Pestalozzi, Manuela Rabaglio, Karin Ribi, Christoph Rochlitz, Karin Rothgiesser, Beat Thürlimann, Roger von Moos, Khalil Zaman, Aron Goldhirsch
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): P4-15-11.
https://doi.org/10.1158/1538-7445.SABCS14-P4-15-11
Published: 01 May 2015
View article titled, Abstract P4-15-11: Advanced HER2 positive breast cancer treated with trastuzumab: Is combination with chemotherapy always needed? Randomized phase III trial SAKK 22/99
Journal Articles

Abstract 5714: Combination of glucagon-like-peptide-1 (GLP-1) receptor targeted therapy with anti-angiogenic compounds in a mouse model of neuroendocrine tumors

Free
Andreas Wicki, Damian Wild, Annette Orleth, Christoph Rochlitz, Christoph Mamot, Gerhard Christofori
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 5714.
https://doi.org/10.1158/1538-7445.AM2012-5714
Published: 15 April 2012
View article titled, Abstract 5714: Combination of glucagon-like-peptide-1 (GLP-1) receptor targeted therapy with anti-angiogenic compounds in a mouse model of neuroendocrine tumors
Journal Articles

Abstract 3634: Selective targeting of tumor-associated angiogenic tip and stalk cells with immunoliposomes (ILs) directed against VEGFR-2 and VEGFR-3 expressing cells

Free
Andreas Wicki, Christoph Rochlitz, Annette Orleth, Reto Ritschard, Kari Alitalo, Richard Herrmann, Gerhard Christofori, Christoph Mamot
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 3634.
https://doi.org/10.1158/1538-7445.AM2011-3634
Published: 15 April 2011
View article titled, Abstract 3634: Selective targeting of tumor-associated angiogenic tip and stalk cells with immunoliposomes (ILs) directed against VEGFR-2 and VEGFR-3 expressing cells
Journal Articles

Abstract #3669: Combined therapy with doxorubicin loaded vascular- and tumor-targeted immunoliposomes in wildtype and multidrug-resistant breast cancer xenografts

Free
Matyas Ecsedi, Andreas Wicki, Reto Ritschard, Richard Herrmann, Christoph Rochlitz, Christoph Mamot
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 3669.
Published: 01 May 2009
View article titled, Abstract #3669: Combined therapy with doxorubicin loaded vascular- and tumor-targeted immunoliposomes in wildtype and multidrug-resistant breast cancer xenografts
Journal Articles

Abstract #3657: Targeting of VEGFR-2 expressing endothelial cells with cytotoxic compounds as a novel anti-angiogenic approach

Free
Andreas Wicki, Christoph Rochlitz, Reto Ritschard, Gerhard Christofori, Christoph Mamot
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 3657.
Published: 01 May 2009
View article titled, Abstract #3657: Targeting of VEGFR-2 expressing endothelial cells with cytotoxic compounds as a novel anti-angiogenic approach
Journal Articles

Preliminary results of a phase I clinical trial of doxorubicin-loaded anti-EGFR immunoliposomes (anti-EGFR ILs-dox ) in EGFR overexpressing solid tumors

Free
Christoph Mamot, Reto Ritschard, Priska Stillhart, Richard Herrmann, Christoph Rochlitz
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 5743.
Published: 01 May 2008
View article titled, Preliminary results of a phase I clinical trial of doxorubicin-loaded anti-EGFR immunoliposomes (anti-EGFR ILs-dox ) in EGFR overexpressing solid tumors
Journal Articles

Bench to bedside development of anti-EGFR immunoliposomes for targeted drug delivery

Free
Christoph Mamot, Reto Ritschard, Willy Kueng, John Park, Richard Herrmann, Christoph Rochlitz
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 1487.
Published: 01 May 2007
View article titled, Bench to bedside development of anti-EGFR immunoliposomes for targeted drug delivery
Journal Articles

Anthracylines can bypass multidrug-resistance mechanisms via receptor-specific immunoliposomal delivery in EGFR overexpressing tumor cells

Free
Christoph Mamot, Willy Kueng, Reto Ritschard, Richard Herrmann, John W. Park, Christoph Rochlitz
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 721–722.
Published: 15 April 2006
View article titled, Anthracylines can bypass multidrug-resistance mechanisms via receptor-specific immunoliposomal delivery in EGFR overexpressing tumor cells
Journal Articles

Epidermal Growth Factor Receptor–Targeted Immunoliposomes Significantly Enhance the Efficacy of Multiple Anticancer Drugs In vivo

Free
Christoph Mamot, Daryl C. Drummond, Charles O. Noble, Verena Kallab, Zexiong Guo, Keelung Hong, Dmitri B. Kirpotin, John W. Park
Journal: Cancer Research
Cancer Res (2005) 65 (24): 11631–11638.
https://doi.org/10.1158/0008-5472.CAN-05-1093
Published: 15 December 2005
View article titled, Epidermal Growth Factor Receptor–Targeted Immunoliposomes Significantly Enhance the Efficacy of Multiple Anticancer Drugs In vivo
Open the PDF for Epidermal Growth Factor Receptor–Targeted Immunoliposomes Significantly Enhance the Efficacy of Multiple Anticancer Drugs In vivo in another window
Journal Articles

Anti-EGFR immunoliposomes mediate specific and efficient drug delivery to target cells and can overcome multidrug-resistance

Free
Christoph Mamot, Willy Kueng, Reto Ritschard, Juergen Reuter, Richard Herrmann, Charles Noble, Daryl Drummond, Dmitri Kirpotin, Christoph Rochlitz, John W. Park
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 334.
Published: 01 May 2005
View article titled, Anti-EGFR immunoliposomes mediate specific and efficient drug delivery to target cells and can overcome multidrug-resistance
Journal Articles

Development of novel liposomal and receptor tyrosine kinase-targeted immunoliposomal vinorelbine formulations with improved drug retention

Free
Daryl C. Drummond, Charles O. Noble, Christoph Mamot, Zexiong Guo, Keelung Hong, John W. Park, James D. Marks, Dmitri B. Kirpotin
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1039–1040.
Published: 01 May 2005
View article titled, Development of novel liposomal and receptor tyrosine kinase-targeted immunoliposomal vinorelbine formulations with improved drug retention
Journal Articles

Distribution of Liposomes into Brain and Rat Brain Tumor Models by Convection-Enhanced Delivery Monitored with Magnetic Resonance Imaging

Free
Ryuta Saito, John R. Bringas, Tracy R. McKnight, Michael F. Wendland, Christoph Mamot, Daryl C. Drummond, Dmitri B. Kirpotin, John W. Park, Mitchel S. Berger, Krys S. Bankiewicz
Journal: Cancer Research
Cancer Res (2004) 64 (7): 2572–2579.
https://doi.org/10.1158/0008-5472.CAN-03-3631
Published: 01 April 2004
View article titled, Distribution of Liposomes into Brain and Rat Brain Tumor Models by Convection-Enhanced Delivery Monitored with Magnetic Resonance Imaging
Open the PDF for Distribution of Liposomes into Brain and Rat Brain Tumor Models by Convection-Enhanced Delivery Monitored with Magnetic Resonance Imaging in another window
Journal Articles

Epidermal Growth Factor Receptor (EGFR)-targeted Immunoliposomes Mediate Specific and Efficient Drug Delivery to EGFR- and EGFRvIII-overexpressing Tumor Cells

Free
Christoph Mamot, Daryl C. Drummond, Udo Greiser, Keelung Hong, Dmitri B. Kirpotin, James D. Marks, John W. Park
Journal: Cancer Research
Cancer Res (2003) 63 (12): 3154–3161.
Published: 15 June 2003
View article titled, Epidermal Growth Factor Receptor (EGFR)-targeted Immunoliposomes Mediate Specific and Efficient Drug Delivery to EGFR- and EGFRvIII-overexpressing Tumor Cells
Open the PDF for Epidermal Growth Factor Receptor (EGFR)-targeted Immunoliposomes Mediate Specific and Efficient Drug Delivery to EGFR- and EGFRvIII-overexpressing Tumor Cells in another window